SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
101 hedge funds and large institutions have $590M invested in Syros Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
24% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 29
9% more funds holding
Funds holding: 93 → 101 (+8)
Holders
101
Holding in Top 10
4
Calls
$1.7M
Puts
$1.3M
Top Buyers
| 1 | +$62.8M | |
| 2 | +$17M | |
| 3 | +$17M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$10.8M |
| 5 |
AG
Artal Group
Luxembourg
|
+$3.09M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$10.6M | |
| 3 | -$5.82M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$1.47M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$748K |